Cure for ADRD (Attention Deficit Relational Disorder) announced!

Impactiviti Pharmaceuticals today announced the approval of Relativiti (aprillinate oneicus), a unique therapy for treating Attention Deficit Relational Disorder (ADRD).
ADRD is a syndrome that affects approximately 96% of all males, and is characterized by a lack of listening skills, a disinterest in spousal conversation, and an obsession with sports and beer at the expense of [...]

Read Full Post »

As Heard on The Street

This week, I was surprised to receive a phone call from a mainstream reporter (TheStreet.com), asking for my opinions on small business branding. Many of you may not be aware that, beside my full-time work consulting with pharmaceutical companies, I also do some work in the marketing/branding arena (in fact, I have a separate blog, [...]

Read Full Post »

Pharma News 3_30

A bonanza of cardiology news!
Novartis’ new HPB drug, Tekturna, shows solid results used with Diovan.
Angiomax from The Medicines Company is effective in anti-clotting trial (anti-clotting is big news these days…)
Schering-Plough has promising results for its investigational blood thinner.
New heart failure drug: symptom relief, but no extended life (a single, but everyone still looking for the [...]

Read Full Post »

Book Review: Gadgets, Games, and Gizmos for Learning

Karl M. Kapp is a professor of instructional technology at Bloomsburg University, and this new book, due for release in mid-April, takes on a very important topic in learning/training – namely, how to move knowledge from one generation of workers (the Boomers) to the newest generation (the Gamers), when there is a gap not only [...]

Read Full Post »

After Hours 3_30

I like word games. Boggle is a favorite, and Scrabble is also enjoyable…except for the time it takes, waiting (snoozing…) while others take 8.5 minutes to decide to put down the word “CRAB” over the Triple Word Score box you had planned to use for “QUIXOTIC.”
But there is a fast-pace variant of Scrabble called [...]

Read Full Post »

Are Pharma Sales Reps Obsolete?

I don’t think so. But a lot of the mainstream press wants to portray pharma sales representatives as valueless leeches on the healthcare marketplace, seeking for all the wrong reasons to influence doctors to prescribe drugs for all the wrong reasons.
There are plenty of articles on rep/cheerleaders, on office lunches, on giveaways, on off-label promotions [...]

Read Full Post »

Some limits for on-line learning

From the Wall Street Journal:
Companies Find Online Training Has Its Limits
By GEORGE ANDERS
March 26, 2007
Home Depot Inc. likes computer-based training — most of the time. When the big Atlanta-based retailer hires new cashiers, it marches them through online simulations of making change and processing credit cards. Recruits learn so quickly that training time has shrunk [...]

Read Full Post »

Sweet Sixteen

If I might be indulged just a bit of alma mater boosterism…
Go Vandy!
Vanderbilt has reached the Sweet 16 in the NCAA basketball tournament. They might not be good enough to reach the Final Four – but then again, they’ve knocked off some excellent teams all season, including Florida. Mrs. Impactress’ alma mater, UConn, is absent [...]

Read Full Post »

Pharma News 3_16

Schering to buy Organon. Will there be any mid-sized pharmas left by 2009?
How does your sales force rank? (hint: the top two in this survey both begin with “B”). More here on Pharmalot, one of your best daily sources for pharma news and comment.
GSK’s CEO Garnier with some comments on sales/marketing costs – the 4th [...]

Read Full Post »

Impact Interview – Measuring Training

Impactiviti recently interviewed Greg Sapnar, Associate Director, Metrics and Adaptation, Learning and Organization Development, Bristol-Myers Squibb. The topic of this Impact Interview is Measuring Training – an endeavor that occupies the majority of Greg’s professional attention. In his current role, Greg is tasked with developing and implementing standards and tools for measuring learning outcomes. Previously, [...]

Read Full Post »